Cite
Gadaleta RM, Garcia-Irigoyen O, Cariello M, et al. Corrigendum to 'Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor': [EBioMedicine 54 (2020) 102719]. EBioMedicine. 2020;57:102873doi: 10.1016/j.ebiom.2020.102873.
Gadaleta, R. M., Garcia-Irigoyen, O., Cariello, M., Scialpi, N., Peres, C., Vetrano, S., Fiorino, G., Danese, S., Ko, B., Luo, J., Porru, E., Roda, A., Sabbá, C., & Moschetta, A. (2020). Corrigendum to 'Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor': [EBioMedicine 54 (2020) 102719]. EBioMedicine, 57102873. https://doi.org/10.1016/j.ebiom.2020.102873
Gadaleta, Raffaella Maria, et al. "Corrigendum to 'Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor': [EBioMedicine 54 (2020) 102719]." EBioMedicine vol. 57 (2020): 102873. doi: https://doi.org/10.1016/j.ebiom.2020.102873
Gadaleta RM, Garcia-Irigoyen O, Cariello M, Scialpi N, Peres C, Vetrano S, Fiorino G, Danese S, Ko B, Luo J, Porru E, Roda A, Sabbá C, Moschetta A. Corrigendum to 'Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor': [EBioMedicine 54 (2020) 102719]. EBioMedicine. 2020 Jul;57:102873. doi: 10.1016/j.ebiom.2020.102873. Epub 2020 Jul 07. PMID: 32650271; PMCID: PMC7348001.
Copy
Download .nbib